Equities research analysts expect Tivity Health Inc (NASDAQ:TVTY) to report sales of $138.34 million for the current fiscal quarter, according to Zacks Investment Research. Five analysts have provided estimates for Tivity Health’s earnings. The lowest sales estimate is $137.69 million and the highest is $138.70 million. Tivity Health posted sales of $124.93 million during the same quarter last year, which suggests a positive year over year growth rate of 10.7%. The company is expected to issue its next quarterly earnings report on Thursday, February 22nd.

On average, analysts expect that Tivity Health will report full-year sales of $138.34 million for the current year, with estimates ranging from $555.20 million to $556.30 million. For the next financial year, analysts anticipate that the firm will post sales of $615.82 million per share, with estimates ranging from $606.10 million to $620.23 million. Zacks’ sales calculations are an average based on a survey of sell-side research analysts that follow Tivity Health.

Tivity Health (NASDAQ:TVTY) last issued its quarterly earnings results on Thursday, October 26th. The company reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.10. The firm had revenue of $137.70 million for the quarter, compared to analyst estimates of $137.95 million. Tivity Health had a return on equity of 30.23% and a net margin of 11.45%. Tivity Health’s quarterly revenue was up 10.2% compared to the same quarter last year.

A number of equities research analysts have weighed in on TVTY shares. Zacks Investment Research raised Tivity Health from a “sell” rating to a “hold” rating in a report on Wednesday, September 6th. Oppenheimer lifted their price objective on Tivity Health from $47.00 to $50.00 and gave the company an “outperform” rating in a report on Wednesday, November 1st. Chardan Capital started coverage on Tivity Health in a report on Tuesday, August 29th. They set a “neutral” rating and a $40.00 price objective on the stock. ValuEngine downgraded Tivity Health from a “buy” rating to a “hold” rating in a report on Monday, October 2nd. Finally, Jefferies Group reaffirmed a “buy” rating and set a $46.00 price objective on shares of Tivity Health in a report on Monday, September 25th. Two analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $46.25.

In related news, insider Mary Flipse sold 7,808 shares of the business’s stock in a transaction that occurred on Monday, September 25th. The shares were sold at an average price of $39.00, for a total value of $304,512.00. Following the completion of the transaction, the insider now owns 57,975 shares in the company, valued at approximately $2,261,025. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Conan Laughlin sold 115,087 shares of the business’s stock in a transaction that occurred on Wednesday, November 15th. The stock was sold at an average price of $33.87, for a total transaction of $3,897,996.69. The disclosure for this sale can be found here. Insiders sold a total of 890,837 shares of company stock worth $32,405,634 over the last three months. 8.42% of the stock is owned by company insiders.

Hedge funds have recently bought and sold shares of the stock. Flinton Capital Management LLC raised its position in Tivity Health by 63.5% in the 2nd quarter. Flinton Capital Management LLC now owns 3,502 shares of the company’s stock worth $139,000 after purchasing an additional 1,360 shares during the last quarter. Riverhead Capital Management LLC raised its position in Tivity Health by 69.7% in the 2nd quarter. Riverhead Capital Management LLC now owns 3,564 shares of the company’s stock worth $142,000 after purchasing an additional 1,464 shares during the last quarter. SG Americas Securities LLC bought a new position in Tivity Health in the 3rd quarter worth approximately $210,000. Crossmark Global Holdings Inc. bought a new position in Tivity Health in the 3rd quarter worth approximately $279,000. Finally, Piedmont Investment Advisors LLC bought a new position in Tivity Health in the 2nd quarter worth approximately $290,000.

Shares of Tivity Health (NASDAQ:TVTY) opened at $35.85 on Monday. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.60 and a current ratio of 0.60. The firm has a market capitalization of $1,420.27, a P/E ratio of 21.86, a price-to-earnings-growth ratio of 2.03 and a beta of 0.20. Tivity Health has a 1-year low of $20.60 and a 1-year high of $48.50.

WARNING: “Zacks: Analysts Expect Tivity Health Inc (TVTY) Will Post Quarterly Sales of $138.34 Million” was first published by American Banking News and is the property of of American Banking News. If you are reading this article on another domain, it was illegally stolen and reposted in violation of US and international trademark & copyright legislation. The legal version of this article can be read at https://www.americanbankingnews.com/2017/12/04/zacks-analysts-expect-tivity-health-inc-tvty-will-post-quarterly-sales-of-138-34-million.html.

Tivity Health Company Profile

Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.

Get a free copy of the Zacks research report on Tivity Health (TVTY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.